Tucker Edwin Jonathan's Form 4 filing
Mirum Pharmaceuticals, Inc. (MIRM) · filed Oct 1, 2021
- Accession no.
- 0001209191-21-058604
- Filed
- Oct 1, 2021
- Trade date
- Sep 29-Oct 1, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $26.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tucker Edwin JonathanCIK 0001792296 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2021 | Common Stock | AGrant or awardAcquired | +8,125 | $0.00 | $0 | 47,132 | Direct | |
| Oct 1, 2021 | Common Stock | SSaleDisposed | −1,364 | $19.26 | −$26,270.64 | 45,768 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.